Clinical and Functional Outcome of the MobileLink Acetabular Cup System in the Short-, Mid-, and Longterm Follow-up

Launched by WALDEMAR LINK GMBH & CO. KG · Dec 23, 2020

Keywords

ClinConnect Summary

This clinical trial is studying the MobileLink acetabular cup system, which is a type of artificial hip joint, to see how well it works for patients with hip osteoarthritis. The goal is to gather information on how patients feel about the results of their surgery over time, including their satisfaction with the new hip joint. Since this is a common surgery, understanding the outcomes can help improve future care for patients.

To participate in the trial, you need to be at least 18 years old and have the MobileLink hip prosthesis implanted. However, some people may not be eligible, including those who are very overweight (with a BMI of 40 or more) or those who have had previous surgeries on the hip joint. Participants can expect regular follow-ups to monitor their recovery and experiences with the prosthesis. The trial is currently recruiting participants, and everyone involved will have the opportunity to share their feedback on the implant's performance.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Implantation of a MobileLink acetabular cup system and a femoral stem manufactured by Waldemar Link
• • Age ≥ 18 years
• • Fully signed patient informed cons
• Exclusion Criteria:
• • Revisions
• • Body Mass Index (BMI) ≥ 40 kg/m²
• • Patient who is foreseeable not able to understand the study and the study-related circumstances
• • Patients who is foreseeable non-compliant to the treatment and the follow-ups
• • Pregnant or breast-feeding women
• • Prisoner